The TSX Venture Exchange has accepted for filing a loan agreement between the company and Auramet International Inc., dated Feb. 19, 2026, whereby the lender provides a $30-million (U.S.) secured credit facility to the company. The credit facility consists of a $15-million (U.S.) tranche 1 amount made available on March 9, 2026, and a $15-million (U.S.) tranche 2 amount to be made available during the period commencing 90 days following the closing date and ending 180 days following the closing date. The loan has a maturity date of 24 months from the closing date and bears interest at 12 per cent per annum, with no interest accruing on tranche 1 for the first six months.

In connection with the credit facility, the company issued 1,369,600 common shares in the capital of the company at a deemed price of $1.05 (Canadian) per common share as consideration for the arrangement of the credit facility. Additionally, in connection with tranche 1, the company issued: (i) 489,142 common shares at a deemed price of $1.05 (Canadian) per common share as consideration for the tranche 1 drawdown fee; and (ii) 4.5 million common share purchase warrants, with each common share purchase warrant exercisable to purchase one common share at an exercise price equal to $1.07 (Canadian) per common share until the maturity date, subject to acceleration.

For further details, refer to the company's news releases dated Feb. 20, 2026, and March 9, 2026.